UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                        WASHINGTON, D.C. 20549

                             SCHEDULE 13G
                             (RULE13d-102)


      INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
 RULES 13d-1(b), (c), and (d) AND AMENDMENTS THERETO FILED PURSUANT TO
                             RULE 13d-2(b)

                           (AMENDMENT NO. 1)


                        PAIN THERAPEUTICS, INC.
                        -----------------------
                           (Name of Issuer)

                    Common Stock, $0.001 par value
                    ------------------------------
                    (Title of Class of Securities)

                               69562K100
                               ---------
                            (CUSIP Number)

                           December 31, 2003
                           -----------------
        (Date of Event Which Requires Filing of This Statement)

          Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

          [x]  Rule 13d-1(b)

          [ ]  Rule 13d-1(c)

          [ ]  Rule 13d-1(d)


          *The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a
prior cover page.

          The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).




CUSIP 69562K100             SCHEDULE 13G             Page 2 of 5 Pages

 1    Name of Reporting Person     WENTWORTH, HAUSER & VIOLICH, INC.(1) 

      IRS Identification No. of Above Person
 2    Check the Appropriate Box if a member of a Group           (a) [ ]

                                                                 (b) [ ]
 3    SEC USE ONLY

 4    Citizenship or Place of Organization      WASHINGTON, UNITED STATES

   NUMBER OF        5    Sole Voting Power                              0
     SHARES
  BENEFICIALLY      6    Shared Voting Power                    1,558,095
 OWNED BY EACH
   REPORTING        7    Sole Dispositive Power                         0
  PERSON WITH
                    8    Shared Dispositive Power               1,558,095

  9    Aggregate Amount Beneficially Owned by Each Reporting
       Person                                                   1,558,095

 10    Check Box if the Aggregate Amount in Row (9) Excludes Certain
       Shares                                                         [ ]

 11    Percent of Class Represented by Amount in Row 9               4.4%

 12    Type of Reporting Person                                        IA


- ------------------------

    (1)This Schedule 13G Amendment No. 1 to the Schedule 13G filed with
the SEC via EDGAR on February 13, 2003 by Wentworth, Hauser & Violich, Inc.
and Laird Norton Financial Group, Inc. (the "Initial Schedule 13G") is
filed only as to Wentworth, Hauser & Violich, Inc., and does not amend
any of the information in the Initial Schedule 13G regarding Laird
Norton Financial Group, Inc.



CUSIP 69562K100             SCHEDULE 13G             Page 3 of 5 Pages

Item 1(a).     Name of Issuer.

               Pain Therapeutics, Inc.

Item 1(b).     Address of Issuer's Principal Executive Offices.

               416 Browning Way
               South San Francisco, CA  94080

Item 2(a).     Name of Person Filing.

               Wentworth, Hauser & Violich, Inc. ("Wentworth")

Item 2(b).     Address of Principal Business Office or, if none,
               Residence.

               353 Sacramento Street, Suite 600
               San Francisco, CA  94111

Item 2(c).     Citizenship.

               Washington, United States

Item 2(d).     Title of Class of Securities.

               Common Stock, $0.001 par value

Item 2(e).     CUSIP Number.

               69562K100

Item 3.        Type of Reporting Person.

               If this statement is filed pursuant to Rule 13d-1(b) or
               Rule 13d-2(b) or (c), check whether the person filing
               is a:

               (a) [ ] Broker or dealer registered under section 15
                       of the Exchange Act.

               (b) [ ] Bank as defined in section 3(a)(6) of the
                       Exchange Act.

               (c)[ ] Insurance company as defined in section
                      3(a)(19) of the Exchange Act.

               (d)[ ] Investment company registered under section 8
                      of the Investment Company Act of 1940.

               (e)[x] An investment adviser in accordance with Rule
                      13d-1(b)(1)(ii)(E);

               (f)[ ] An employee benefit plan or endowment fund in
                      accordance with Rule 13d-1(b)(1)(ii)(F);



CUSIP 69562K100             SCHEDULE 13G             Page 4 of 5 Pages

               (g)[ ] A parent holding company or control person in
                      accordance with Rule 13d-1(b)(1)(ii)(G);

               (h)[ ] A savings association as defined in Section
                      3(b) of the Federal Deposit Insurance Act;

               (i)[ ] A church plan that is excluded from the
                      definition of an investment company under section
                      3(c)(14) of the Investment Company Act of 1940;

               (j)[ ] Group, in accordance with Rule
                      13d-1(b)(1)(ii)(J).

Item 4.        Ownership.

               Reference is hereby made to Items 5-9 and 11 of page two (2)
of this Schedule 13G, which Items are incorporated by reference herein.

               Under the definition of "beneficial ownership" in Rule 13d-3
under the Securities Exchange Act of 1934, it is also possible that the
individual directors, executive officers, and/or shareholders of
Wentworth might be deemed the "beneficial owners" of some or all of the
securities to which this Schedule relates in that they might be deemed
to share the power to direct the voting or disposition of such
securities.  Neither the filing of this Schedule nor any of its
contents shall be deemed to constitute an admission that any of such
individuals is, for any purpose, the beneficial owner of any of the
securities to which this Schedule relates, and such beneficial
ownership is expressly disclaimed.

Item 5.        Ownership of Five Percent or Less of a Class.

              If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the
following [X].

Item 6.        Ownership of More Than Five Percent on Behalf of Another
               Person.

               Not applicable.

Item 7.        Identification and Classification of the Subsidiary Which
               Acquired the Security Being Reported on by the Parent Holding
               Company.

               Not applicable.

Item 8.        Identification and Classification of Members of the Group.

               Not applicable.



CUSIP 69562K100             SCHEDULE 13G             Page 5 of 5 Pages

Item 9.        Notice of Dissolution of Group.

               Not applicable.

Item 10.       Certification.

               By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.



                               Signature
                               ---------

               After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this statement is
true, complete and correct.


                                 WENTWORTH, HAUSER & VIOLICH, INC.



                                 By:/s/ Bradford Hall
                                    ---------------------------------------
                                    Bradford Hall, Chief Compliance Officer




DATED:  February 5, 2004